Skip to main content

Academics

Groundbreaking Chronic Pain Study Needs Participants: Find Out What You Can Do to Help

[Courtesy of Americans for Safe Access]

Dear ASA Supporter,

Dr. Donald Abrams of University of California, San Francisco needs individuals who are currently using Oxycontin or MS Contin to join an important medical cannabis study! This research could potentially provide clinical proof that when added to conventional narcotic pain drugs, marijuana can provide added relief and often allow much-reduced doses of these dangerous narcotics.

Dr. Abrams has conducted numerous groundbreaking medical marijuana studies and you could be involved in his next historic project! Time is of the essence, be one of two dozen people to impact medical marijuana research for the future.

In order to ensure that this necessary research continues and is a success, Dr. Abrams is seeking out individuals who meet the following qualifications:

To qualify, you must:
  • Be taking either OxyContin or MS Contin (or Kadian) twice daily;
  • Have smoked marijuana at least 6 times in the past;
  • Be willing NOT to smoke marijuana for a month prior to screening for the study;
  • Be willing not to smoke cigarettes at least 2 weeks prior to screening and through the study;
  • Be 18 years or older;
  • Meet some additional criteria;

    And you cannot:
  • Be pregnant, trying to become pregnant, or breastfeeding;
  • Be on chemo, radiation, or other cancer therapy;
  • Be currently using alcohol or recreational drugs;
  • Have kidney or liver failure, severe heart problems, high blood pressure, lung disease or a severe psychiatric disorder.
  • The study takes place at San Francisco General Hospital, in the clinical research center, and is a 5-day inpatient stay. Participants may be eligible to receive up to $520.00 for travel reimbursements. You can read more about the study here: www.AmericansforSafeAccess.org/AbramsPainStudy

    How to Get Involved:
    If you meet the qualifications above and are interested in participating in this historical research please contact Paul Couey at: 415-476-9554 ext 315 or e-mail at: [email protected]. Let Paul know you found out about this study from ASA.

    If you do not meet the criteria above, there is still an important role for you to play! Please forward this message on to any lists you belong to, any community members you know might be interested, and your family and friends!

    If you have questions about the study or need more information, please contact [email protected]

    Sincerely,

    Sonnet Seeborg Gabbard
    Field Coordinator
    Americans for Safe Access

    Global Conference on Methamphetamine - Abstract Submission Deadline Extended

    Abstract Submission Deadline extended to April 22nd, 2008! Abstract Submission Guidelines Topics and areas to be discussed include: Pharmacology * Research * Trafficking * Treatment * Policy * Mental Health * Global Markets * HIV * Hepatitis * Community Education * Law Enforcement * Women *Trafficking * Production * Epidemiology * Demand Reduction * Harm Reduction * Public Health * MSM Sexual Risk * Youth * Environmental Issues * Commerce * Rapid Assessment* Replacement Therapy * Injection Drug Use * Asia * Prescribed Usage * Central Asia * Eastern Europe * Caribbean * Latin America * Oceania * North America * Western & Central Europe * Sub-Saharan Africa 1) Individual proposals for presentations are welcome. 2) Presentation formats may include individual papers, reports on research-in-progress, round-table discussions, topic-centred workshops, or a format more appropriate to your own work. - Please indicate your presentation format in your proposal. - Please make sure that your proposal identifies the language you wish to present in. 3) Please send a 250-word proposal - along with a short bio - to the email address below. - Your abstract should not contain more than 250 words. - No abstract will be accepted without a short bio. Please send your abstract to [email protected]. The Deadline for abstract submissions is April 22, 2008, 20:00 GMT. Speakers will be notified by May 2nd, 2008. Please email Luciano Colonna at [email protected] with any questions or concerns. Register now and benefit from the standard registration fee until June 1, 2008. Hotel and travel information can be found at www.globalmethconference.com

    New JPI Report: Jail populations exploding; massive growth devastating local communities

    Washington, D.C.: Communities are bearing the cost of a massive explosion in the jail population which has nearly doubled in less than two decades, according to a new report released today by the Justice Policy Institute (JPI). The research found that jails are now warehousing more people--who have not been found guilty of any crime--for longer periods of time than ever before. The research shows that in part due to the rising costs of bail, people arrested today are much more likely to serve jail time before trial than they would have been twenty years ago, even though crime rates are nearly at the lowest levels in thirty years. "Crime rates are down, but you're more likely to serve time in jail today than you would have been twenty years ago," said the report's co-author Amanda Petteruti. "Jail bonds have skyrocketed, so that means if you're poor, you do time. People are being punished before they're found guilty-justice is undermined." The report, Jailing Communities: The Impact of Jail Expansion and Effective Public Safety Strategies, found jail population growth (22 percent), is having serious consequences for communities that are now paying tens of billions yearly to sustain jails. Jails are filled with people with drug addictions, the homeless and people charged with immigration offenses. The report concludes that jails have become the "new asylums," with six out of 10 people in jail living with a mental illness. The impact of increased jail imprisonment is not borne equally by all members of a community. New data reveal that Latinos are most likely to have to pay bail, have the highest bail amounts, are least likely to be able to pay and, by far, the least likely to be released prior to trial. African Americans are nearly five times as likely to be incarcerated in jails as whites and almost three times as likely as Latinos. Further exacerbating jail crowding problems is the increase in the number of people being held in jails for immigration violations-up 500 percent in the last decade. In 2004, local governments spent a staggering $97 billion on criminal justice, including police, the courts and jails. Over $19 billion of county money went to financing jails alone. By way of comparison, during the same time period, local governments spent just $8.7 billion on libraries and only $28 billion on higher education. "These counties just cannot afford to invest the bulk of their local public safety budget in jails, and we are beginning to see why--the more a community relies on jails, the less it has to invest in education, employment and proven public safety strategies," says Nastassia Walsh, co-author of the report. Research shows that places that increased their jail populations did not necessarily see a drop in violent crimes. Falling jail incarceration rates are associated with declining violent crime rates in some of the country's largest counties and cities, like New York City. "The investment in building more jail beds is not making communities safer," says Derrick Johnson, NAACP National Board member. "Instead these investments serve only to unfairly target communities of color and waste taxpayer dollars." The report recommends that communities take action to reduce their jail populations and increase public safety by: * Improving release procedures for pretrial and sentenced populations. Implementing pretrial release programs that release people from jail before trial can help alleviate jail populations. Reforming bail guidelines would allow a greater number of people to post bail, leaving space open in jails for people who may pose a greater threat to public safety. * Developing and implementing alternatives to incarceration. Alternatives such as community-based corrections would permit people to be removed from the jail, allowing them to continue to work, stay with their families, and be part of the community, while under supervision. * Re-examining policies that lock up individuals for nonviolent crimes. Reducing the number of people in jail for nonviolent offenses leaves resources and space available for people who may need to be detained for a public safety reason. * Diverting people with mental health and drug treatment needs to the public health system and community-based treatment. People who suffer from mental health or substance abuse problems are better served by receiving treatment in their community. Treatment is more cost-effective than incarceration and promotes a positive public safety agenda. * Diverting spending on jail construction to agencies that work on community supervision and make community supervision effective. Reallocating funding to probation services will allow people to be placed in appropriate treatment or other social services and is a less costly investment in public safety. * Providing more funding for front-end services such as education, employment, and housing. Research has shown that education, employment, drug treatment, health care, and the availability of affordable housing coincide with lower crime rates. For more information on Jailing Communities, contact LaWanda Johnson at 202-558-7974, ext. 308. ### The Justice Policy Institute is a Washington, D.C.-based think tank dedicated to ending society's reliance on incarceration and promoting effective and just solutions to social problems. For more information, visit www.justicepolicy.org.

    Cannabis Has "Clear Medical Benefits" For HIV Patients, Study Says

    [Courtesy of NORML] Cannabis Has "Clear Medical Benefits" For HIV Patients, Study Says Smoked marijuana produces "substantial and comparable increases in food intake...with little evidence of discomfort and no impairment of cognitive performance" New York, NY: Inhaling cannabis significantly increases daily caloric intake and body weight in HIV-positive patients, is well tolerated, and does not impair subjects’ cognitive performance, according to clinical trial data to be published in the Journal of Acquired Immune Deficiency Syndromes (JAIDS). Investigators at Columbia University in New York assessed the efficacy of inhaled cannabis and oral THC (Marinol) in a group of ten HIV-positive patients in a double-blind, placebo-controlled trial. All of the subjects participating in the study had prior experience using marijuana therapeutically and were taking at least two antiretroviral medications. Researchers reported that smoking cannabis (2.0 or 3.9 percent THC) four times daily "produced substantial … increases in food intake … with little evidence of discomfort and no impairment of cognitive performance." On average, patients who smoked higher-grade cannabis (3.9 percent) increased their body weight by 1.1 kg over a four-day period. Researchers reported that inhaling cannabis increased the number of times subjects ate during the study, but did not alter the average number of calories consumed during each meal. Investigators said that the administration of oral THC produced similar weight gains in patients, but only at doses that were "eight times current recommendations." The US Food and Drug Administration approved the prescription use of Marinol (a gelatin capsule containing synthetic THC in sesame oil) to treat HIV/AIDS-related cachexia in 1992. Subjects in the study reported feeling intoxicated after using either cannabis or oral THC, but remarked that these effects were "positive" and "well tolerated." Although not a primary outcome measure of the trial, authors reported that patients made far fewer requests for over-the-counter medications while taking either cannabis or oral THC than they did when administered placebo. Most of these requests were to treat patients’ gastrointestinal complaints (nausea, diarrhea, and upset stomach), investigators said. Patients in the study also reported that smoking higher-strength marijuana subjectively improved their sleep better than oral THC. "The data demonstrate that over four days of administration, smoked marijuana and oral [THC] produced a similar range of positive effects: increasing food intake and body weight and producing a ‘good [drug] effect’ without producing uncomfortable levels of intoxication or impairing cognitive function," authors wrote. They added, "Smoked marijuana … has a clear medical benefit in HIV-positive [subjects] by increasing food intake and improving mood and objective and subjective sleep measures." A previous preliminary trial by Columbia investigators published in the journal Psychopharmacology in 2005 also reported that inhaling cannabis "produce[s] substantial … increases in food intake [in HIV+ positive patients] without producing adverse effects." Survey data indicates that an estimated one out of three HIV/AIDS patients in North America use cannabis therapeutically to combat symptoms of the disease or the side-effects of antiretroviral medications. Clinical trial data published in the Annals of Internal Medicine in 2003 reported that cannabis use by HIV patients is associated with increased CD4/T-cell counts compared to non-users. A separate study published in JAIDS in 2005 found that HIV/AIDS patients who report using medical marijuana are 3.3 times more likely to adhere to their antiretroviral therapy regimens than non-cannabis users. Most recently, investigators at San Francisco General Hospital and the University of California's Pain Clinical Research Center reported this year in the journal Neurology that inhaling cannabis significantly reduced HIV-associated neuropathy (nerve pain) compared to placebo. The Columbia University study is one of the first US-led clinical trials to evaluate the efficacy of smoked cannabis to take place in nearly two decades, and it is the first to compare the tolerability and efficacy of smoked marijuana and oral THC in HIV patients. For more information, please contact Paul Armentano, NORML Senior Policy Analyst, at: [email protected]. Full text of the study, "Dronabinol and marijuana in HIV-positive marijuana smokers: caloric intake, mood, and sleep," will appear in the Journal of Acquired Immune Deficiency Syndromes. Further discussion of this trial is available on the Thursday, June 28 edition of the NORML Daily Audio Stash, online at: http://www.normlaudiostash.com.

    DPA Press Release: Lawmakers, judges, and advocates rebuke Gov. O’Malley’s veto of sentencing reform bill

    For Immediate Release: May 17, 2007 Contact: Naomi Long (202) 669-6071 or Laura Jones: (202) 425-4659 Lawmakers, judges, and advocates rebuke Gov. O’Malley’s veto of sentencing reform bill; O’Malley “clinging to the failed policies of the past” in a “lapse of leadership” Coalition vows to continue educating O’Malley, promoting treatment instead of prisons Annapolis—A coalition of advocates, law enforcement officials, drug treatment providers and policy experts today denounced Governor O’Malley’s veto of a bill that would have provided the possibility of parole for non-violent drug offenders. The sentencing reform bill, HB 992, was one of the only bills vetoed by O’Malley, despite its support from the legislature, the coalition, and the editorial pages of the Washington Post and Baltimore Sun. “The veto is a disappointing mistake,” said Justice Policy Institute executive director Jason Ziedenberg. “Instead of taking a baby step in the right direction towards treatment instead of prison, O’Malley is stubbornly clinging to the failed tough on crime policies of the past. The governor failed to show leadership and vision in this decision.” States across the country have taken steps to reform ineffective mandatory sentencing laws that remove discretion to consider the individual facts of the case. Newly-elected Massachusetts Governor Deval Patrick (D) recently called for wide ranging mandatory minimum sentencing reform. Newly-elected New York Governor Elliot Spitzer added language in his budget for a prison closure commission, and is considering a bill to further reform the state’s Rockefeller Drug Laws. Under the comparatively modest Maryland reform, individuals convicted of a 10-year sentence for a nonviolent drug reform would have been eligible for, but not guaranteed, parole. Individuals convicted of violent crimes would serve the full 10-year sentences. “Governor O’Malley has put Maryland out of step with other states that are moving in the direction of smarter, more effective sentencing policies,” said Naomi Long, Director of the Drug Policy Alliance District of Columbia Metropolitan Area project. “This veto was a lapse of leadership, and hurts Maryland’s efforts to implement the kinds of real reforms that would actually make a difference.” The state of Maryland spends millions of dollars each year incarcerating nonviolent drug offenders, the vast majority of whom would be better served by drug treatment options. A recent report by the Justice Policy Institute found that Maryland's sentencing laws disproportionately affect communities of color and may be the least effective, most expensive way to promote public safety. “The fight for more effective and fair sentencing policies isn’t over,” said Delegate Curtis Anderson (D-Baltimore), a sponsor of the legislation. “Maryland voters want more fair and effective sentencing policies. We will keep working with the Governor to implement those reforms.” The Partnership for Treatment, Not Incarceration supported HB 992, and is a consortium of organizations and individuals including members of faith communities, public health and drug treatment professionals, public defenders, judges, police and other law enforcement. For more information about bill, or to interview spokespeople who can respond, contact Naomi Long (202)669-6071. To learn more about sentencing reform work in Maryland, visit: www.justicepolicy.org and www.drugpolicy.org .

    Supreme Court of New Mexico Strikes Down State’s Attempt to Convict Woman Struggling with Addiction During Pregnancy

    For Immediate Release: May 11, 2007 CONTACT: Reena Szczepanski (DPA): 505-983-3277 or Nancy Goldstein (NAPW): 347-563-1647 Supreme Court of New Mexico Strikes Down State’s Attempt to Convict Woman Struggling with Addiction During Pregnancy Leading Physicians, Scientific Researchers, and Medical, Public Health, and Child Welfare Organizations Applaud Court’s Order On May 11, the Supreme Court of the State of New Mexico turned back the state's attempt to expand the criminal child abuse laws to apply to pregnant women and fetuses. In 2003, Ms. Cynthia Martinez was charged with felony child abuse “for permitting a child under 18 years of age to be placed in a situation that may endanger the child's life or health. . .” In bringing this prosecution, the state argued that a pregnant woman who cannot overcome a drug addiction before she gives birth should be sent to jail as a felony child abuser. Today the Supreme Court summarily affirmed the Court of Appeals decision, which overturned Ms. Martinez’s conviction. New Mexico joins more than 20 other states that have ruled on this issue and that have refused to judicially expand state criminal child abuse and related laws to reach the issues of pregnancy and addiction. The Drug Policy Alliance (“DPA”) and the National Advocates for Pregnant Women (“NAPW”) filed a friend-of-the-court brief http://www.drugpolicy.org/docUploads/NMvMartinezAmicusBrief.pdf on behalf of the New Mexico Public Health Association, the New Mexico Nurses Association, and nearly three dozen other leading medical and public health organizations, physicians, and scientific researchers. During oral argument, the Justices referenced the amicus brief filed by these organizations and expressed grave concerns about the deterrent effect such prosecutions would have on women seeking prenatal care. Tiloma Jayasinghe, NAPW staff attorney, explained, “Making child abuse laws applicable to pregnant women and fetuses would, by definition, make every woman who is low-income, uninsured, has health problems, and/or is battered who becomes pregnant a felony child abuser. In oral argument, the state’s attorney conceded that the law could potentially be applied to pregnant women who smoked.” Reena Szczepanski, Director of Drug Policy Alliance New Mexico, said, “I hope that this case serves as a reminder that pregnant women who are struggling with drug use should be offered prenatal care and drug treatment, not prosecution. There are better ways to protect our children in New Mexico, and ensure that future generations will be safe and healthy.”